Coronary
Drug Coated Balloon

Best investigated DCB

In the last 12 years, B. Braun’s SeQuent® Please product family has demonstrated its functionality and efficacy for coronary lesion therapy underlined with a significant clinical evidence portfolio of more than 110 published studies.

The SeQuent® Please NEO is a drug coated balloon catheter for treating stenosis of coronary arteries with PTCA, while leaving nothing behind. The catheter has a matrix coating of paclitaxel and Iopromide (PACCOCATH®-Technology), which helps to keep coronary arteries open by inhibiting smooth muscle cell proliferation and migration.

THINK ABOUT…

  • Importance of Lesion Preparation for improved clinical outcomes
  • This implant-free treatment requires only one month of DAPT
  • The proven coating technology in more than 110 studies
Learn more about

Clinical evidence

More than 110 clinical trials with over 25,000 enrolled patients. De novo lesions & ISR – Randomized controlled trials and observational studies.

Read more

Sharing expertise

We share the knowledge and experience with our products at various events as webinars and digital congresses, both national and international.

Read more

Case studies

Experience the efficacy of DCB-only as well as of NSE Alpha™ and SeQuent® Please for hematoma post treatment of the left circumflex.

Read more

THINK ABOUT… clinical evidence on drug coated balloons and contact our experts.

Contact us now

Related Documents

Description Document Link
SeQuent® Please NEO Clinically proven drug coated balloon catheter
pdf (1.9 MB) open
SeQuent® Please NEO – Go Implant-Free! Safe and effective alternative to DES in de novo lesions
pdf (27.8 KB) open
Cardiology Catalog Your partner for coronary angioplasty
pdf (1.8 MB) open

Related Product

SeQuent® Please NEO

Next generation coronary Drug Coated Balloon to treat vascular stenosis

Interventional Vascular Therapy
+49 30 568207300
+49 30 568207130
IVT Contact Form
B. Braun Melsungen AG
Sieversufer 8
12359 Berlin
Germany
Google Maps